We hypothesized that reduced SCFA levels in patients with active IBD may be an important factor contributing to increased iNOS expression, as SCFAs were demonstrated to inhibit iNOS expression by the NF-κB pathway [26,27]. Here, NFKB1 is linked to irritable bowel syndrome.